Aquestive Therapeutics (AQST) FCF Margin Growth (3y) (2020 - 2026)
Aquestive Therapeutics (AQST) FCF Margin Growth (3y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 253.00 |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | -1,444.00 |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -990.00 |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | -2,377.00 |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -1,484.00 |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 4,765.00 |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 1,067.00 |
| 10 | Aquestive Therapeutics | 462.24 Mn | 462.24 Mn | 13.47 Mn | -18,201.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -18,201.00 |
| Dec 31, 2025 | -5,225.00 |
| Sep 30, 2025 | -12,445.00 |
| Jun 30, 2025 | 1,189.00 |
| Mar 31, 2025 | -15,102.00 |
| Dec 31, 2024 | 2,156.00 |
| Sep 30, 2024 | -1,888.00 |
| Jun 30, 2024 | 6,279.00 |
| Mar 31, 2024 | 9,111.00 |
| Dec 31, 2023 | 14,184.00 |
| Sep 30, 2023 | 8,518.00 |
| Jun 30, 2023 | 6,041.00 |
| Mar 31, 2023 | 23,624.00 |
| Dec 31, 2022 | 14,347.00 |
| Sep 30, 2022 | 14,244.00 |
| Jun 30, 2022 | 6,475.00 |
| Mar 31, 2022 | 2,394.00 |
| Dec 31, 2021 | -5,795.00 |
| Sep 30, 2021 | 2,102.00 |
| Jun 30, 2021 | -9,667.00 |